Last: | $91.65 |
---|---|
Change Percent: | 0.46% |
Open: | $91.21 |
Close: | $91.23 |
High: | $92.11 |
Low: | $90.61 |
Volume: | 431,728 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$91.65 | $91.21 | $91.23 | $92.11 | $90.61 | 431,728 | 07-03-2024 |
$91.23 | $90 | $91.23 | $91.36 | $89.8 | 1,899,408 | 07-02-2024 |
$90.25 | $90.3 | $90.25 | $93 | $90.18 | 3,277,669 | 07-01-2024 |
$92.37 | $93.59 | $92.37 | $93.99 | $92.18 | 11,670,925 | 06-28-2024 |
$93.34 | $92.16 | $93.34 | $93.62 | $92.16 | 3,309,489 | 06-27-2024 |
$91.56 | $90.72 | $91.56 | $92.14 | $90.18 | 2,854,523 | 06-26-2024 |
$91.08 | $90.36 | $91.08 | $91.15 | $89.52 | 2,747,944 | 06-25-2024 |
$90.17 | $90.9 | $90.17 | $92.16 | $90.15 | 2,718,933 | 06-24-2024 |
$90.9 | $89.61 | $90.9 | $90.965 | $88.86 | 5,269,002 | 06-21-2024 |
$88.84 | $88.08 | $88.84 | $90.49 | $87.06 | 5,442,858 | 06-20-2024 |
$88.52 | $86.89 | $88.52 | $89 | $86.2 | 3,709,988 | 06-19-2024 |
$88.52 | $86.89 | $88.52 | $89 | $86.2 | 3,709,988 | 06-18-2024 |
$86.87 | $85.2 | $86.87 | $87.11 | $85.12 | 2,093,528 | 06-17-2024 |
$87.29 | $87.5 | $87.29 | $87.72 | $86.75 | 1,527,650 | 06-14-2024 |
$87.67 | $87.32 | $87.67 | $87.94 | $86.67 | 1,805,187 | 06-13-2024 |
$87.77 | $87.4 | $87.77 | $89.03 | $87.05 | 2,460,665 | 06-12-2024 |
$87 | $86.01 | $87 | $87.6 | $85.38 | 2,241,876 | 06-11-2024 |
$86.1 | $87.71 | $86.1 | $87.86 | $85.6 | 2,229,429 | 06-10-2024 |
$88.14 | $87.41 | $88.14 | $88.25 | $86.62 | 2,427,051 | 06-07-2024 |
$87.68 | $86.9 | $87.68 | $88.06 | $86.405 | 1,680,361 | 06-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Edwards Lifesciences Corporation Company Name:
EW Stock Symbol:
NYSE Market:
Edwards Lifesciences Corporation Website:
Vancouver, British Columbia--(Newsfile Corp. - June 19, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") announces that the Board of directors has determined that its in the best interest of the Company to return capital to its shareholders by way of a reduction in st...
Edwards Lifesciences (NYSE: EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TAVR) patients with a small annulus. Through five-year follow up of more than 1,300 low and intermediate risk SAPIEN 3 valve p...
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader PR Newswire Combination unlocks new future value-creation opportunities and is expected to be immed...